Earnings History Data for Trevi Therapeutics, Inc. (TRVI) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Trevi Therapeutics, Inc.

Trevi Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. The company is currently developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis and levodopa-induced dyskinesia in patients with Parkinson's disease. Trevi Therapeutics Inc. is based in New Haven, Connecticut.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
20-03-2024 AH TRVI Trevi Therapeutics, Inc. 207.54 -0.08 -0.10 -0.06 Trevi Therapeutics GAAP EPS of -$0.08 beats by $0.01
[3/20/2024 4:22 PM]
3.67 0.13 
(3.81%)
3.49 -0.05 
(-1.41%)
0.97 - 4.00 563,156 310,000 7,107
09-11-2023 AH TRVI Trevi Therapeutics, Inc. 97.37 -0.08 -0.09 -0.12 Trevi Therapeutics GAAP EPS of -$0.08 beats by $0.01
[11/9/2023 4:28 PM]
1.30 -0.05 
(-3.69%)
0.0 0.0 
(0.00%)
1.18 - 3.50 105,799 170,000 0
10-08-2023 AH TRVI Trevi Therapeutics, Inc. 138.16 -0.07 -0.09 -0.14 Trevi Therapeutics GAAP EPS of -$0.07 beats by $0.02
[8/10/2023 5:48 PM]
2.38 -0.01 
(-0.42%)
2.39 0.0 
(0.00%)
1.43 - 4.60 19,642 60,000 6,162
11-05-2023 AH 4:05 PM ET
(May 11)
TRVI Trevi Therapeutics, Inc. 181.34 -0.06 -0.08 -0.24 Trevi Therapeutics GAAP EPS of -$0.06 beats by $0.01
[5/11/2023 4:26 PM]
2.84 -0.16 
(-5.33%)
3.00 0.0 
(0.00%)
1.43 - 4.68 116,338 160,000 15,032
16-03-2023 AH 4:05 PM ET
(Mar 16)
TRVI Trevi Therapeutics, Inc. 137.82 -0.06 -0.10 -0.28 Trevi Therapeutics GAAP EPS of -$0.06 beats by $0.03
[3/16/2023 4:16 PM]
1.80 -0.01 
(-0.55%)
0.0 0.0 
(0.00%)
1.39 - 4.68 31,599 80,000 0
10-11-2022 AH 4:05 PM ET
(Nov 10)
TRVI Trevi Therapeutics, Inc. 112.56 -0.12 -0.15 -0.34 Trevi Therapeutics GAAP EPS of -$0.12 misses by $0.01
[11/10/2022 4:18 PM]
1.97 0.04 
(2.07%)
0.0 0.0 
(0.00%)
0.46 - 4.68 39,587 60,000 0
11-08-2022 AH 4:05 PM ET
(Aug 11)
TRVI Trevi Therapeutics, Inc. 140.43 -0.14 -0.21 -0.49 Trevi Therapeutics GAAP EPS of -$0.14 beats by $0.04
[8/11/2022 4:30 PM]
4.13 -0.14 
(-3.28%)
4.50 0.23 
(5.39%)
0.46 - 4.68 179,033 380,000 506
12-05-2022 AH 4:05 PM ET
(May 12)
TRVI Trevi Therapeutics, Inc. 86.66 -0.24 -0.31 -0.43 Trevi Therapeutics GAAP EPS of -$0.24 beats by $0.04
[5/12/2022 4:30 PM]
2.20 0.15 
(7.32%)
2.03 -0.02 
(-0.98%)
0.46 - 3.73 128,211 210,000 520
17-03-2022 AH 4:05 PM ET
(Mar 17)
TRVI Trevi Therapeutics, Inc. 37.74 -0.28 -0.34 -0.52 Trevi Therapeutics GAAP EPS of -$0.28 misses by $0.03
[3/17/2022 4:26 PM]
1.65 0.12 
(7.84%)
1.61 0.08 
(5.23%)
0.46 - 2.96 279,265 642,059 2,204
10-11-2021 AH 4:05 PM ET
(Nov 10)
TRVI Trevi Therapeutics, Inc. 30.24 -0.34 -0.33 -0.41 Trevi Therapeutics EPS beats by $0.12
[11/10/2021 4:49 PM]
1.16 -0.01 
(-0.80%)
1.15 -0.02 
(-1.71%)
1.10 - 3.98 2,135,360 230,000 1,034
12-08-2021 AH 4:05 PM ET
(Aug 12)
TRVI Trevi Therapeutics, Inc. 44.00 -0.49 -0.46 -0.41 Trevi Therapeutics reports Q2 results
[8/12/2021 4:17 PM]
2.02 -0.08 
(-4.05%)
2.11 0.01 
(0.67%)
1.78 - 6.73 35,004 20,000 110
13-05-2021 AH 4:05 PM ET
(May 13)
TRVI Trevi Therapeutics, Inc. 41.85 -0.43 -0.49 -0.48 Trevi Therapeutics reports Q1 results
[5/13/2021 4:33 PM]
2.03 0.02 
(1.00%)
0.0 0.0 
(0.00%)
1.94 - 8.50 66,717 30,000 0
25-03-2021 AH 4:05 PM ET
(Mar 25)
TRVI Trevi Therapeutics, Inc. 51.83 -0.52 -0.45 -0.19 Trevi Therapeutics reports Q4 results
[3/25/2021 4:18 PM]
2.68 0.16 
(6.35%)
2.70 0.09 
(3.45%)
1.33 - 8.50 21,853 60,000 530
12-11-2020 AH 4:05 PM ET
(Nov 11)
TRVI Trevi Therapeutics, Inc. 61.29 -0.41 -0.59 -0.41 Trevi Therapeutics reports Q3 results
[11/11/2020 4:20 PM]
3.48 -0.34 
(-8.80%)
3.65 -0.17 
(-4.35%)
1.33 - 8.50 26,569 13,646 330
13-08-2020 AH 4:05 PM ET
(Aug 13)
TRVI Trevi Therapeutics, Inc. 103.85 -0.41 -0.51 -0.63 5.68 0.02 
(0.44%)
5.66 0.0 
(0.00%)
1.33 - 8.50 83,680 319,349 1,262